Outcome in Patients with Secundum Type Atrial Septal Defect Referred for Percutaneous or Surgical Closure: A Single-Center Experience
The Thoracic and Cardiovascular Surgeon · 01.01.2026 · 74 (S 03 S 03) · e1-e8
DOI: 10.1055/a-2786-1128 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.01.2026. Verfasst von Johanna Gorenflo und 4 weiteren Autor:innen. Beteiligte Einrichtung: University Medical Centre Mannheim, Ear, Nose and Throat Department, Mannheim, Germany. Hauptthemen laut MEDLINE: Heart Septal Defects, Atrial, Cardiac Catheterization, Cardiac Surgical Procedures. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joachim Siebeneicher Stiftung.
Abstract (Originalsprache)
This single-center, retrospective analysis presents data from 611 patients with a secundum type atrial septal defect (ASD II) closure. Included were patients >2 years of age. Patients presented at a median (range) age of 6.95 (2–86) years for interventional closure of ASD II. Out of 611 patients, 215 underwent intracardiac repair based on transthoracic echocardiography (ECHO) findings. Transcatheter device closure was attempted and successfully performed in 300 out of 396 patients (Amplatzer™ Septal Occluder [ASO], n = 290 patients). Follow-up was 3.3 years (1 day–21.8 years) in patients with interventional closure of ASD II and 0.7 years (3 days–14.7 years; p < 0.001; Mann–Whitney) in patients after surgical closure. There was no in-hospital mortality in both groups. One patient, after Amplatzer device closure with an absent aortic rim, developed erosion, which was treated by cardiac surgery and patch closure of ASD II. Two patients showed dislocation of the device. In 231 out of 396 patients, right ventricular dimension normalized completely as determined on the last follow-up visit. Six patients at a median age of 60 (49.4–68.7) years presented with atrial fibrillation, which persisted after ASD II closure. About 26 patients (6.6%) showed pulmonary hypertension (PH), with 1 presenting with coincidental ASD II and severe PH. Closure of ASD II can be accomplished safely by interventional catheterization and intracardiac repair. In most cases, perioperative transthoracic and transesophageal ECHO is sufficient to decide whether a surgical approach or interventional closure is the best option to close the defect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University Medical Centre Mannheim, Ear, Nose and Throat Department, Mannheim, Germany.
- Department of Paediatric Cardiology, Heidelberg University, Heidelberg, Baden, Germany.
- Department of Congenital Cardiac Surgery, Heidelberg University Medical Centre, Heidelberg, Germany.
ORCID-Profile: Mina Farag, Matthias Gorenflo
Förderung
- Joachim Siebeneicher Stiftung
Zitieren
APA
Gorenflo, J., Ziesenitz, V., Farag, M., Loukanov, T., & Gorenflo, M. (2026). Outcome in Patients with Secundum Type Atrial Septal Defect Referred for Percutaneous or Surgical Closure: A Single-Center Experience. The Thoracic and Cardiovascular Surgeon, 74(S 03 S 03), e1-e8. https://doi.org/10.1055/a-2786-1128
Vancouver
Gorenflo J, Ziesenitz V, Farag M, Loukanov T, Gorenflo M. Outcome in Patients with Secundum Type Atrial Septal Defect Referred for Percutaneous or Surgical Closure: A Single-Center Experience. The Thoracic and Cardiovascular Surgeon. 2026;74(S 03 S 03):e1-e8. doi:10.1055/a-2786-1128
BibTeX
@article{Gorenflo2026,
author = {Gorenflo, Johanna and Ziesenitz, Victoria and Farag, Mina and Loukanov, Tsvetomir and Gorenflo, Matthias},
title = {Outcome in Patients with Secundum Type Atrial Septal Defect Referred for Percutaneous or Surgical Closure: A Single-Center Experience},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2026},
volume = {74},
number = {S 03 S 03},
pages = {e1--e8},
doi = {10.1055/a-2786-1128}
}
EUVIMED